|
US4447A
(en)
|
|
1846-04-04 |
|
Car- wheel |
|
US233A
(en)
|
|
1837-06-14 |
|
Improvement in plows |
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US3691016A
(en)
|
1970-04-17 |
1972-09-12 |
Monsanto Co |
Process for the preparation of insoluble enzymes
|
|
CA1023287A
(en)
|
1972-12-08 |
1977-12-27 |
Boehringer Mannheim G.M.B.H. |
Process for the preparation of carrier-bound proteins
|
|
US3896111A
(en)
|
1973-02-20 |
1975-07-22 |
Research Corp |
Ansa macrolides
|
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US4195128A
(en)
|
1976-05-03 |
1980-03-25 |
Bayer Aktiengesellschaft |
Polymeric carrier bound ligands
|
|
US4330440A
(en)
|
1977-02-08 |
1982-05-18 |
Development Finance Corporation Of New Zealand |
Activated matrix and method of activation
|
|
CA1093991A
(en)
|
1977-02-17 |
1981-01-20 |
Hideo Hirohara |
Enzyme immobilization with pullulan gel
|
|
US4151042A
(en)
|
1977-03-31 |
1979-04-24 |
Takeda Chemical Industries, Ltd. |
Method for producing maytansinol and its derivatives
|
|
US4137230A
(en)
|
1977-11-14 |
1979-01-30 |
Takeda Chemical Industries, Ltd. |
Method for the production of maytansinoids
|
|
US4229537A
(en)
|
1978-02-09 |
1980-10-21 |
New York University |
Preparation of trichloro-s-triazine activated supports for coupling ligands
|
|
US4307016A
(en)
|
1978-03-24 |
1981-12-22 |
Takeda Chemical Industries, Ltd. |
Demethyl maytansinoids
|
|
US4265814A
(en)
|
1978-03-24 |
1981-05-05 |
Takeda Chemical Industries |
Matansinol 3-n-hexadecanoate
|
|
US4263428A
(en)
|
1978-03-24 |
1981-04-21 |
The Regents Of The University Of California |
Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
|
|
JPS5562090A
(en)
|
1978-10-27 |
1980-05-10 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
|
JPS5566585A
(en)
|
1978-11-14 |
1980-05-20 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
|
JPS55164687A
(en)
|
1979-06-11 |
1980-12-22 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
|
US4256746A
(en)
|
1978-11-14 |
1981-03-17 |
Takeda Chemical Industries |
Dechloromaytansinoids, their pharmaceutical compositions and method of use
|
|
JPS55102583A
(en)
|
1979-01-31 |
1980-08-05 |
Takeda Chem Ind Ltd |
20-acyloxy-20-demethylmaytansinoid compound
|
|
JPS55162791A
(en)
|
1979-06-05 |
1980-12-18 |
Takeda Chem Ind Ltd |
Antibiotic c-15003pnd and its preparation
|
|
JPS55164685A
(en)
|
1979-06-08 |
1980-12-22 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
|
JPS6023084B2
(ja)
|
1979-07-11 |
1985-06-05 |
味の素株式会社 |
代用血液
|
|
US4309428A
(en)
|
1979-07-30 |
1982-01-05 |
Takeda Chemical Industries, Ltd. |
Maytansinoids
|
|
JPS5645483A
(en)
|
1979-09-19 |
1981-04-25 |
Takeda Chem Ind Ltd |
C-15003phm and its preparation
|
|
EP0028683A1
(en)
|
1979-09-21 |
1981-05-20 |
Takeda Chemical Industries, Ltd. |
Antibiotic C-15003 PHO and production thereof
|
|
JPS5645485A
(en)
|
1979-09-21 |
1981-04-25 |
Takeda Chem Ind Ltd |
Production of c-15003pnd
|
|
WO1982001188A1
(en)
|
1980-10-08 |
1982-04-15 |
Takeda Chemical Industries Ltd |
4,5-deoxymaytansinoide compounds and process for preparing same
|
|
US4450254A
(en)
|
1980-11-03 |
1984-05-22 |
Standard Oil Company |
Impact improvement of high nitrile resins
|
|
US4315929A
(en)
|
1981-01-27 |
1982-02-16 |
The United States Of America As Represented By The Secretary Of Agriculture |
Method of controlling the European corn borer with trewiasine
|
|
US4313946A
(en)
|
1981-01-27 |
1982-02-02 |
The United States Of America As Represented By The Secretary Of Agriculture |
Chemotherapeutically active maytansinoids from Trewia nudiflora
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
US4475196A
(en)
|
1981-03-06 |
1984-10-02 |
Zor Clair G |
Instrument for locating faults in aircraft passenger reading light and attendant call control system
|
|
JPS57192389A
(en)
|
1981-05-20 |
1982-11-26 |
Takeda Chem Ind Ltd |
Novel maytansinoid
|
|
US4640835A
(en)
|
1981-10-30 |
1987-02-03 |
Nippon Chemiphar Company, Ltd. |
Plasminogen activator derivatives
|
|
EP0088046B1
(de)
|
1982-02-17 |
1987-12-09 |
Ciba-Geigy Ag |
Lipide in wässriger Phase
|
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
|
US4447224A
(en)
|
1982-09-20 |
1984-05-08 |
Infusaid Corporation |
Variable flow implantable infusion apparatus
|
|
US4487603A
(en)
|
1982-11-26 |
1984-12-11 |
Cordis Corporation |
Implantable microinfusion pump system
|
|
US4486194A
(en)
|
1983-06-08 |
1984-12-04 |
James Ferrara |
Therapeutic device for administering medicaments through the skin
|
|
HUT35524A
(en)
|
1983-08-02 |
1985-07-29 |
Hoechst Ag |
Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
|
|
DE3474511D1
(en)
|
1983-11-01 |
1988-11-17 |
Terumo Corp |
Pharmaceutical composition containing urokinase
|
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
EP0206448B1
(en)
|
1985-06-19 |
1990-11-14 |
Ajinomoto Co., Inc. |
Hemoglobin combined with a poly(alkylene oxide)
|
|
US5681930A
(en)
|
1985-12-20 |
1997-10-28 |
Bristol-Myers Squibb Company |
Anti-oncostatin M monoclonal antibodies
|
|
JPS63502716A
(ja)
|
1986-03-07 |
1988-10-13 |
マサチューセッツ・インステチュート・オブ・テクノロジー |
糖タンパク安定性の強化方法
|
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5011912A
(en)
|
1986-12-19 |
1991-04-30 |
Immunex Corporation |
Hybridoma and monoclonal antibody for use in an immunoaffinity purification system
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
US4965195A
(en)
|
1987-10-26 |
1990-10-23 |
Immunex Corp. |
Interleukin-7
|
|
US4968607A
(en)
|
1987-11-25 |
1990-11-06 |
Immunex Corporation |
Interleukin-1 receptors
|
|
AU643427B2
(en)
|
1988-10-31 |
1993-11-18 |
Immunex Corporation |
Interleukin-4 receptors
|
|
ATE102631T1
(de)
|
1988-11-11 |
1994-03-15 |
Medical Res Council |
Klonierung von immunglobulin sequenzen aus den variabelen domaenen.
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US6291158B1
(en)
|
1989-05-16 |
2001-09-18 |
Scripps Research Institute |
Method for tapping the immunological repertoire
|
|
US5683888A
(en)
|
1989-07-22 |
1997-11-04 |
University Of Wales College Of Medicine |
Modified bioluminescent proteins and their use
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5292658A
(en)
|
1989-12-29 |
1994-03-08 |
University Of Georgia Research Foundation, Inc. Boyd Graduate Studies Research Center |
Cloning and expressions of Renilla luciferase
|
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
CA2050918A1
(en)
|
1990-01-12 |
1991-07-13 |
Raju Kucherlapati |
Generation of xenogeneic antibodies
|
|
ZA912136B
(en)
*
|
1990-03-29 |
1992-11-25 |
Bristol Myers Squibb Co |
Anti-oncostatin m monoclonal antibodies
|
|
AU651596B2
(en)
|
1990-06-05 |
1994-07-28 |
Immunex Corporation |
Type II interleukin-1 receptors
|
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
DK0575319T3
(da)
|
1991-03-11 |
2000-07-10 |
Univ Georgia Res Found |
Kloning og ekspression af Renilla-luciferase
|
|
US5262522A
(en)
|
1991-11-22 |
1993-11-16 |
Immunex Corporation |
Receptor for oncostatin M and leukemia inhibitory factor
|
|
ATE408012T1
(de)
|
1991-12-02 |
2008-09-15 |
Medical Res Council |
Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
|
|
US5714350A
(en)
|
1992-03-09 |
1998-02-03 |
Protein Design Labs, Inc. |
Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
|
|
DK0563475T3
(da)
|
1992-03-25 |
2000-09-18 |
Immunogen Inc |
Konjugater af cellebindende midler og derivater af CC-1065
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US6239328B1
(en)
|
1992-10-05 |
2001-05-29 |
North Carolina State University |
Method for reducing expression variability of transgenes in plant cells
|
|
WO1994010308A1
(en)
|
1992-10-23 |
1994-05-11 |
Immunex Corporation |
Methods of preparing soluble, oligomeric proteins
|
|
DE69329974T2
(de)
|
1992-12-04 |
2001-07-19 |
Medical Research Council, London |
Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung
|
|
US5457035A
(en)
|
1993-07-23 |
1995-10-10 |
Immunex Corporation |
Cytokine which is a ligand for OX40
|
|
JP3810791B2
(ja)
|
1993-09-10 |
2006-08-16 |
ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨーク |
緑色蛍光タンパク質の使用
|
|
WO1995021191A1
(en)
|
1994-02-04 |
1995-08-10 |
William Ward |
Bioluminescent indicator based upon the expression of a gene for a modified green-fluorescent protein
|
|
US5783672A
(en)
|
1994-05-26 |
1998-07-21 |
Immunex Corporation |
Receptor for oncostatin M
|
|
US5777079A
(en)
|
1994-11-10 |
1998-07-07 |
The Regents Of The University Of California |
Modified green fluorescent proteins
|
|
US5874304A
(en)
|
1996-01-18 |
1999-02-23 |
University Of Florida Research Foundation, Inc. |
Humanized green fluorescent protein genes and methods
|
|
US5804387A
(en)
|
1996-02-01 |
1998-09-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
FACS-optimized mutants of the green fluorescent protein (GFP)
|
|
US5876995A
(en)
|
1996-02-06 |
1999-03-02 |
Bryan; Bruce |
Bioluminescent novelty items
|
|
US5925558A
(en)
|
1996-07-16 |
1999-07-20 |
The Regents Of The University Of California |
Assays for protein kinases using fluorescent protein substrates
|
|
US6037525A
(en)
|
1996-08-01 |
2000-03-14 |
North Carolina State University |
Method for reducing expression variability of transgenes in plant cells
|
|
US5976796A
(en)
|
1996-10-04 |
1999-11-02 |
Loma Linda University |
Construction and expression of renilla luciferase and green fluorescent protein fusion genes
|
|
DK1500329T3
(da)
|
1996-12-03 |
2012-07-09 |
Amgen Fremont Inc |
Humane antistoffer, der specifikt binder TNF-alfa
|
|
JP3795533B2
(ja)
|
1996-12-12 |
2006-07-12 |
プロルーム・リミテツド |
感染性物質を検出及び同定するための方法及び装置
|
|
US6245974B1
(en)
|
1997-08-06 |
2001-06-12 |
North Carolina State University |
Matrix attachment regions
|
|
GB9722131D0
(en)
|
1997-10-20 |
1997-12-17 |
Medical Res Council |
Method
|
|
GB9806530D0
(en)
|
1998-03-26 |
1998-05-27 |
Glaxo Group Ltd |
Inflammatory mediator
|
|
JP2002507410A
(ja)
|
1998-03-27 |
2002-03-12 |
プロルーム・リミテッド |
ルシフェラーゼ、蛍光タンパク質、ルシフェラーゼおよび蛍光タンパク質をコードする核酸および、診断、高処理スクリーニングおよび新規アイテムにおけるその使用
|
|
US6177612B1
(en)
|
1998-07-31 |
2001-01-23 |
Her Majesty The Queen In Right Of Canada, As Represented By The Department Of Agriculture And Agri-Food Canada |
Matrix attachment regions
|
|
WO2000018938A1
(en)
|
1998-09-29 |
2000-04-06 |
Pioneer Hi-Bred International, Inc. |
Mar/sar elements flanking rsyn7-driven construct
|
|
US6833268B1
(en)
|
1999-06-10 |
2004-12-21 |
Abgenix, Inc. |
Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
|
|
DK1242401T3
(da)
|
1999-11-24 |
2007-05-07 |
Immunogen Inc |
Cytotoksiske midler, der omfatter taxaner, og den terapeutiske anvendelse deraf
|
|
US20030096339A1
(en)
|
2000-06-26 |
2003-05-22 |
Sprecher Cindy A. |
Cytokine receptor zcytor17
|
|
KR100408844B1
(ko)
|
2000-07-29 |
2003-12-06 |
한국산업기술평가원 |
동물세포 발현벡터
|
|
US6333410B1
(en)
|
2000-08-18 |
2001-12-25 |
Immunogen, Inc. |
Process for the preparation and purification of thiol-containing maytansinoids
|
|
AU2002216443A1
(en)
|
2000-12-15 |
2002-06-24 |
Pangen Biotech Inc. |
Expression vector for animal cell containing nuclear matrix attachment region fointerferon beta
|
|
SG141239A1
(en)
|
2001-01-26 |
2008-04-28 |
Selexis Sa |
Matrix attachment regions and methods for use thereof
|
|
JP4303105B2
(ja)
|
2001-06-28 |
2009-07-29 |
ドマンティス リミテッド |
二重特異性リガンドとその利用
|
|
WO2004003019A2
(en)
|
2002-06-28 |
2004-01-08 |
Domantis Limited |
Immunoglobin single variant antigen-binding domains and dual-specific constructs
|
|
US7230167B2
(en)
|
2001-08-31 |
2007-06-12 |
Syngenta Participations Ag |
Modified Cry3A toxins and nucleic acid sequences coding therefor
|
|
AU2003280410B8
(en)
|
2002-01-18 |
2009-04-23 |
Zymogenetics, Inc. |
Cytokine receptor zcytor17 multimers
|
|
ES2310660T3
(es)
|
2002-01-18 |
2009-01-16 |
Zymogenetics, Inc. |
Citoquina (ligando zcytor17).
|
|
US7317091B2
(en)
|
2002-03-01 |
2008-01-08 |
Xencor, Inc. |
Optimized Fc variants
|
|
EP1542723B1
(en)
|
2002-08-16 |
2011-02-23 |
ImmunoGen, Inc. |
Cross-linkers with high reactivity and solubility and their use in the preparation of conjugates for targeted delivery of small molecule drugs
|
|
AU2003290330A1
(en)
|
2002-12-27 |
2004-07-22 |
Domantis Limited |
Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand
|
|
US7755007B2
(en)
|
2003-04-17 |
2010-07-13 |
K&H Manufacturing, Inc |
Heated pet mat
|
|
ATE514783T1
(de)
|
2003-11-12 |
2011-07-15 |
Schering Corp |
Plasmidsystem zur expression mehrerer gene
|
|
US7235641B2
(en)
|
2003-12-22 |
2007-06-26 |
Micromet Ag |
Bispecific antibodies
|
|
JP4803789B2
(ja)
*
|
2004-02-03 |
2011-10-26 |
独立行政法人科学技術振興機構 |
疼痛を処置するための薬学的組成物
|
|
WO2005084390A2
(en)
|
2004-03-02 |
2005-09-15 |
Seattle Genetics, Inc. |
Partially loaded antibodies and methods of their conjugation
|
|
EP1730191B1
(en)
|
2004-03-30 |
2011-07-06 |
Glaxo Group Limited |
Immunoglobulin binding hosm
|
|
CN114053429A
(zh)
|
2004-06-01 |
2022-02-18 |
健泰科生物技术公司 |
抗体-药物偶联物和方法
|
|
JP2008521828A
(ja)
|
2004-11-29 |
2008-06-26 |
シアトル ジェネティックス， インコーポレイテッド |
操作された抗体およびイムノコンジュゲート
|
|
US7301019B2
(en)
|
2005-01-21 |
2007-11-27 |
Immunogen, Inc. |
Method for the preparation of maytansinoid esters
|
|
US7572896B2
(en)
*
|
2005-02-03 |
2009-08-11 |
Raven Biotechnologies, Inc. |
Antibodies to oncostatin M receptor
|
|
CA2594490A1
(en)
|
2005-02-14 |
2006-08-24 |
Zymogenetics Inc. |
Methods of treating skin disorders using an il-31ra antagonist
|
|
US8101183B2
(en)
|
2005-05-06 |
2012-01-24 |
Zymogentics, Inc. |
Variable region sequences of IL-31 monoclonal antibodies
|
|
WO2007143231A2
(en)
*
|
2006-01-10 |
2007-12-13 |
Zymogenetics, Inc. |
Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists
|
|
AU2006244180B2
(en)
|
2005-05-06 |
2012-03-01 |
Zymogenetics, Inc. |
IL-31 monoclonal antibodies and methods of use
|
|
US8858935B2
(en)
|
2005-05-19 |
2014-10-14 |
Amgen Inc. |
Compositions and methods for increasing the stability of antibodies
|
|
EP3673919A1
(en)
|
2005-06-14 |
2020-07-01 |
Amgen Inc. |
Self-buffering protein formulations
|
|
MX336033B
(es)
|
2005-08-03 |
2016-01-07 |
Immunogen Inc |
Formulaciones de inmunoconjugado.
|
|
CA2617953C
(en)
|
2005-08-09 |
2013-12-17 |
Millennium Pharmaceuticals, Inc. |
Method of acylating maytansinol with chiral amino acids
|
|
JP5349058B2
(ja)
|
2006-03-01 |
2013-11-20 |
トムソン ライセンシング |
メディア・パッケージを生成するためのデバイスおよび方法
|
|
KR101317235B1
(ko)
|
2006-04-21 |
2013-10-15 |
조마 테크놀로지 리미티드 |
길항제 항-ｃｄ40 항체 제약 조성물
|
|
AU2007255753B2
(en)
|
2006-06-08 |
2013-01-17 |
Chugai Seiyaku Kabushiki Kaisha |
Preventive or remedy for inflammatory disease
|
|
CA2660175C
(en)
|
2006-09-01 |
2015-05-12 |
Zymogenetics, Inc. |
Variable region sequences of il-31 monoclonal antibodies and methods of use
|
|
EP2097447A4
(en)
*
|
2006-11-15 |
2010-12-29 |
Medarex Inc |
HUMAN MONOCLONAL ANTIBODIES AGAINST BTLA AND METHODS OF USE
|
|
ES2381788T3
(es)
|
2007-07-16 |
2012-05-31 |
Genentech, Inc. |
Anticuerpos anti-CD79b e inmunoconjugados y métodos de uso
|
|
US7695963B2
(en)
|
2007-09-24 |
2010-04-13 |
Cythera, Inc. |
Methods for increasing definitive endoderm production
|
|
AU2008333131B2
(en)
|
2007-12-07 |
2013-10-24 |
Merck Serono S/A |
Humanized antibody molecules specific for IL-31
|
|
AU2009204501B2
(en)
|
2008-01-07 |
2015-02-12 |
Amgen Inc. |
Method for making antibody Fc-heterodimeric molecules using electrostatic steering effects
|
|
HUE029869T2
(en)
|
2008-01-31 |
2017-04-28 |
Genentech Inc |
Anti-cd79b antibodies and immunoconjugates and methods of use
|
|
KR20210005318A
(ko)
|
2008-04-30 |
2021-01-13 |
이뮤노젠 아이엔씨 |
가교제 및 그 용도
|
|
BRPI1006998A2
(pt)
|
2009-01-23 |
2015-08-25 |
Biogen Idec Inc |
Polipeptídeos fc estabilizados com função efetora reduzida e métodos de uso
|
|
TWI609698B
(zh)
|
2010-01-20 |
2018-01-01 |
Chugai Pharmaceutical Co Ltd |
穩定化的含抗體溶液製劑
|
|
CN107693791B
(zh)
|
2010-02-26 |
2022-06-07 |
诺沃—诺迪斯克有限公司 |
包含稳定抗体的组合物
|
|
WO2013168829A1
(en)
*
|
2012-05-11 |
2013-11-14 |
Wakayama Medical University |
Anti oncostatin m receptor beta antibody
|
|
US9401875B2
(en)
|
2012-06-01 |
2016-07-26 |
Nippon Telegraph And Telephone Corporation |
Packet transfer processing method and packet transfer processing device
|
|
US8883979B2
(en)
|
2012-08-31 |
2014-11-11 |
Bayer Healthcare Llc |
Anti-prolactin receptor antibody formulations
|
|
TR201815608T4
(tr)
|
2013-05-30 |
2018-11-21 |
Kiniksa Pharmaceuticals Ltd |
Onkastatin m reseptörü antijeni bağlayıcı proteinler.
|
|
US9550828B2
(en)
|
2013-09-05 |
2017-01-24 |
Boise State University |
Oncostatin M (OSM) antagonists for preventing cancer metastasis and IL-6 related disorders
|
|
US9209965B2
(en)
|
2014-01-14 |
2015-12-08 |
Microsemi Semiconductor Ulc |
Network interface with clock recovery module on line card
|
|
US9300829B2
(en)
|
2014-04-04 |
2016-03-29 |
Canon Kabushiki Kaisha |
Image reading apparatus and correction method thereof
|
|
CA3235178A1
(en)
|
2017-03-01 |
2018-09-07 |
Medimmmune Limited |
Formulations of monoclonal antibodies
|
|
AU2018251808B2
(en)
|
2017-04-11 |
2025-04-10 |
Kiniksa Pharmaceuticals, Ltd. |
Stable anti-OSMR antibody formulation
|